ID

34474

Descripción

Comprehensive Analysis of Hypoxia in Prostate Cancer: Diagnostic Markers and Prognostic Significance; ODM derived from: https://clinicaltrials.gov/show/NCT01191099

Link

https://clinicaltrials.gov/show/NCT01191099

Palabras clave

  1. 17/1/19 17/1/19 -
  2. 27/5/19 27/5/19 -
Titular de derechos de autor

see on clinicaltrials.gov

Subido en

17 de enero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Prostate Cancer NCT01191099

Eligibility Prostate Cancer NCT01191099

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with biopsy-proven adenocarcinoma of the prostate who are to be treated with radical prostatectomy at the department of urology, university hospital of zurich
Descripción

ID.1

Tipo de datos

boolean

written informed consent
Descripción

ID.2

Tipo de datos

boolean

Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
metastatic prostate cancer
Descripción

ID.3

Tipo de datos

boolean

contraindications to the class of investigational product under study, e.g. known hypersensitivity or allergy to the investigational product
Descripción

ID.4

Tipo de datos

boolean

severe heart or lung disease
Descripción

ID.5

Tipo de datos

boolean

severe liver or kidney dysfunction
Descripción

ID.6

Tipo de datos

boolean

severe stridor
Descripción

ID.7

Tipo de datos

boolean

distant metastases
Descripción

ID.8

Tipo de datos

boolean

concurrent treatment for other malignant disease
Descripción

ID.9

Tipo de datos

boolean

prior hormonal therapy or radiotherapy
Descripción

ID.10

Tipo de datos

boolean

Similar models

Eligibility Prostate Cancer NCT01191099

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
patients with biopsy-proven adenocarcinoma of the prostate who are to be treated with radical prostatectomy at the department of urology, university hospital of zurich
boolean
ID.2
Item
written informed consent
boolean
Item Group
C0680251 (UMLS CUI)
ID.3
Item
metastatic prostate cancer
boolean
ID.4
Item
contraindications to the class of investigational product under study, e.g. known hypersensitivity or allergy to the investigational product
boolean
ID.5
Item
severe heart or lung disease
boolean
ID.6
Item
severe liver or kidney dysfunction
boolean
ID.7
Item
severe stridor
boolean
ID.8
Item
distant metastases
boolean
ID.9
Item
concurrent treatment for other malignant disease
boolean
ID.10
Item
prior hormonal therapy or radiotherapy
boolean

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial